Glycemic variability and diabetes retinopathy: A missing link

被引:58
作者
Hsu, Cherng-Ru [1 ]
Chen, Yu-Tsung [2 ]
Sheu, Wayne H. -H. [3 ,4 ,5 ,6 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Med Educ, Taipei, Taiwan
[2] Taipei Med Univ, Wan Fang Hosp, Dept Dermatol, Taipei, Taiwan
[3] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol, Taichung, Taiwan
[4] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[5] Natl Chung Hsing Univ, Inst Med Technol, Taichung 40227, Taiwan
[6] Natl Def Med Ctr, Sch Med, Taipei, Taiwan
关键词
Diabetes retinopathy; Glycemic variability; Postprandial hyperglycemia; Microvascular complications; Macrovascular complications; FASTING PLASMA-GLUCOSE; MICROVASCULAR COMPLICATIONS; POSTPRANDIAL HYPERGLYCEMIA; RISK-FACTOR; BLOOD-GLUCOSE; CARDIOVASCULAR MORTALITY; BETA-CELL; TYPE-1; PREDICTOR; MELLITUS;
D O I
10.1016/j.jdiacomp.2014.11.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Daily glucose variability, such as fasting plasma glucose fluctuation or postprandial hyperglycemia, has been proposed as contributors to diabetes-related macrovascular complications. However, its impacts on microvascular complications, such as diabetes retinopathy remain controversial. We reviewed the current evidence of the relationship between glycemic variability and diabetes retinopathy in patients with type 1 or type 2 diabetes. In general, the short-term glycemic fluctuation, either expressed as standard deviation of fasting glucose or mean glucose levels, may contribute to the development or progression of diabetic retinopathy in patients with type 2 diabetes, whereas long-term glycemic fluctuation, reflected by variation of levels of HbA1c, appeared to show a stronger association with diabetes retinopathy both in patients with type 1 and type 2 diabetes. These findings emphasize the need to reduce glycemic variability by various measures in order to reduce development and progression of diabetes retinopathy both in type 1 and type 2 diabetes patients. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:302 / 306
页数:5
相关论文
共 57 条
[1]   Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S14-S80
[2]  
[Anonymous], 1995, DIABETES, V44, P968
[3]  
[Anonymous], SURVEY OPHTHALMOLOGY
[4]  
[Anonymous], N ENGL J MED
[5]   Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor.: The DECODE Study [J].
Balkau, B ;
Hu, G ;
Qiao, Q ;
Tuomilehto, J ;
Borch-Johnsen, K ;
Pyörälä, K .
DIABETOLOGIA, 2004, 47 (12) :2118-2128
[6]   Optimizing the Replacement of Basal Insulin in Type 1 Diabetes Mellitus: No Longer an Elusive Goal in the Post-NPH Era [J].
Bolli, Geremia B. ;
Andreoli, Anna Marinelli ;
Lucidi, Paola .
DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 :S43-52
[7]   Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria [J].
Borch-Johnsen, K ;
Neil, A ;
Balkau, B ;
Larsen, S ;
Nissinen, A ;
Pekkanen, J ;
Tuomilehto, J ;
Jousilahti, P ;
Lindstrom, J ;
Pyörälä, M ;
Pyörälä, K ;
Eschwege, E ;
Gallus, G ;
Garancini, MP ;
Bouter, LM ;
Dekker, JM ;
Heine, RJ ;
Nijpels, HG ;
Stehouwer, CDA ;
Feskens, EJM ;
Kromhout, D ;
Peltonen, M ;
Pajak, A ;
Eriksson, J ;
Qiao, Q .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) :397-405
[8]   Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? [J].
Bragd, J. ;
Adamson, U. ;
Backlund, L. B. ;
Lins, P. E. ;
Moberg, E. ;
Oskarsson, P. .
DIABETES & METABOLISM, 2008, 34 (06) :612-616
[9]   Glycemic variability:: A hemoglobin A1c-independent risk factor for diabetic complications [J].
Brownlee, M ;
Hirsch, IB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (14) :1707-1708
[10]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820